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Abstract
We have investigated the hypothesis that uridine 5-
diphosphate (UDP)-glucuronyltransferases (UGTs) and
-glucuronidase are jointly involved in a mechanism for
the storage and mobilization of iodothyronine metabolites
in liver, kidney, heart and brain. Specifically, we predicted
UGT activities to decrease and increase respectively, and
-glucuronidase activity to increase and decrease respect-
ively in hypo- and hyperthyroidism. To this end we have
studied the eﬀects of thyroid status on the activities of
diﬀerent enzymes involved in thyroid hormone metab-
olism in liver, kidney, heart and brain from adult rats with
experimentally induced hypo- and hyperthyroidism. We
used whole organ homogenates to determine the specific
enzyme activities of phenol- and androsteron-UGT,
-glucuronidase, as well as iodothyronine deiodinase types
I and II. Deiodinase type I activities in liver and kidney
were decreased in hypothyroid animals and, in liver only,
increased in hyperthyroidism. Deiodinase type II activity
was increased in hyperthyroid rat kidney only. Interest-
ingly, in the heart, deiodinase type I-specific activity was
increased fourfold, although the increase was not statisti-
cally significant. Cardiac deiodinase type I activity was
detectable but not sensitive to thyroid status. Hepatic
phenol-UGT as well as androsteron-UGT activities were
decreased in hypothyroid rats, with specific androsteron-
UGT activities two to three orders of magnitude lower
than phenol-UGT activities. Both UGT isozymes were
well above detection limits in heart, but appeared to
be insensitive to thyroid status. In contrast, cardiac
-glucuronidase activity decreased in hypothyroid tissue,
whereas the activity of this enzyme in the other organs
investigated did not change significantly.
In summary, cardiac -glucuronidase, albeit in low
levels, and hepatic phenol-UGT activities were responsive
only to experimental hypothyroidism. Although a high
basal activity of the pleiotropic -glucuronidase masking
subtle activity changes in response to thyroid status cannot
be ruled out, we conclude that hepatic, renal and cardiac
UGT and -glucuronidase activities are not regulated
reciprocally with thyroid status.
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Introduction
The main secretory product of the mammalian thyroid
gland is thyroxine (T4). Deiodination of T4 to form
3,5,3-triiodothyronine (T3) is an important metabolic path-
way, as are glucuronidation and sulfation to form glucuroni-
dated and sulfated thyroid hormone conjugates respectively.
Both conjugates are considered to be biologically inactive
and have an increased water solubility, facilitating urinary
and biliary excretion. In the last decade, interest in the
glucuronidation of thyroid hormones has been growing
because of the increased knowledge that many drugs and
xenobiotics influence thyroid hormone glucuronidation
(Findlay et al. 2000) and, hence, thyroid status.
We have previously shown that neonatal rat cardiac
fibroblasts, in contrast to cardiomyocytes, are capable of
glucuronidating thyroid hormones (van der Heide et al.
2002). This is one of few examples of extrahepatic
glucuronidation of iodothyronines, and this could be
relevant for local thyroid hormone metabolism in the
heart. The enzymes responsible for thyroid hormone
glucuronidation belong to the family of uridine 5-
diphosphate (UDP)-glucuronyltransferases (UGTs) of
which many diﬀerent isoforms have been identified (see
review by Mackenzie et al., 1997). UGTs are not only
capable of the detoxification and activation of drugs and
xenobiotics (Armstrong & Cozza 2003), but are also
involved in the metabolism of important endogenous
substrates, e.g. bilirubin and thyroid hormones. The
biochemical characterization of the diﬀerent isoforms is
complicated due to the broad substrate specificity (i.e. one
isoform glucuronidates a wide range of substrates) and
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overlapping substrate aﬃnities (i.e. one substrate is
metabolized by more than one isoform) (de Wildt et al.
1999). Three UGT isoforms are known to be involved
in glucuronidating iodothyronines: phenol-UGT (or
UGT1A9) and bilirubin-UGT (or UGT1A1), which
utilize T4 and rT3, and androsteron-UGT (or UGT2B7),
which utilizes T3 as an acceptor for a glucuronyl residue
(Visser et al. 1993, Mackenzie et al. 1997).
Glucuronidated compounds are susceptible to deconju-
gation by -glucuronidase, an enzyme that is widely
distributed in mammalian tissues and localized intracellu-
larly in lysosomes and endoplasmic reticulum. Combined
actions of UGTs and -glucuronidase may play a role in
futile cycling in which conjugated metabolites undergo
successive cycles of synthesis to the glucuronide and
hydrolysis back to the aglycone (Brunelle & Verbeeck
1993). As opposed to sulfated iodothyronine conjugates, of
which for example T4 sulfate is not susceptible to decon-
jugation by sulfatase activity in vitro (Mol & Visser 1985),
glucuronidated T4 and glucuronidated T3 conjugates can
be deconjugated by -glucuronidase activity to yield the
native thyroid hormones (Hays & Hsu 1987, van der
Heide et al. 2002). We therefore propose a functional role
of conjugating and deconjugating mechanisms in the
cycling of iodothyronines from a pool of stored inactivated
hormones.
Based on experimental data from our group and others,
and considering the observations that fibroblasts constitute
two-thirds of the total cardiac cell population (Zak 1973,
Tomoda et al. 2001), we suggest a role of UGT and
-glucuronidase in the storage and mobilization of
iodothyronines from a pool of inactive hormones in heart.
Therefore, we investigated the eﬀects of thyroid status on
the activities of a number of enzymes involved in this
proposed mechanism, e.g. phenol- and androsteron-UGT
and -glucuronidase, as well as deiodinase types I and II,
in heart, liver, kidney and brain from adult rats with
induced hyper- and hypothyroidism.
Materials and Methods
Materials
All reagents used for cell isolation and cell culture
were obtained from Life Technologies BV (Breda,
The Netherlands), with the exception of trypsin
(Boehringer, Mannheim, Germany). Polystyrene 24-well
culture dishes were from Corning Costar Europe
(Badhoevedorp, The Netherlands). Iodothyronines
(3,5,3-triiodothyronine (T3), 3,3,5-triiodothyronine
(rT3) and T4), 6-n-propyl-2-thiouracil (PTU), --
glucuronidase, -dithiothreitol (-DTT), uridine 5-
diphosphoglucuronic acid (UDPGA), p-nitrophenol
(pNP) and BSA (fraction V) were purchased from
Sigma Chemical Co. (St Louis, MO, USA). [125I]T3
(81·4 TBq/mmol), [125I]rT3 (29·9 TBq/mmol) and
[125I]T4 (4·3 TBq/mmol) were obtained from NEN Life
Science Products, Inc. (Boston, MA, USA). [3H]ouabain
(666 GBq/mmol) was obtained from Perkin Elmer
(Boston, MA, USA). Sephadex LH-20 was purchased
from Amersham Pharmacia Biotech Benelux (Roosendaal,
The Netherlands). All other chemicals were analytical
grade and obtained from commercial suppliers.
Animals
Adult Wistar rats (6–10 weeks) were obtained from
laboratory stock (Utrecht University, The Netherlands)
and made hypo- and hyperthyroid respectively. To attain
hypothyroidism, we employed an established protocol (van
Hardeveld & Clausen 1984) in which rats were fed for
7 weeks an iodide-deficient diet with distilled water
during the first 2 weeks and drinking water containing
144 mM KClO4 for five consecutive weeks. This treat-
ment has proven to result in the classic picture of
hypothyroidism with decreased plasma T4 and T3 levels
and rises in thyrotropin (TSH) (Golstein et al. 1988, Yu
et al. 2002). Controls received the same diet, and drinking
water to which 6·5 mg/l KI was added. To induce
hyperthyroidism, rats were injected subcutaneously with
20 µg T3/100 g body weight daily for 2 weeks; controls
received daily injections with 0·9% saline (Everts &
Clausen 1988). Rats were killed by decapitation and
organs were quickly dissected and processed as described
below. All experiments were approved by the local ethical
review committee.
Isolation of tissues
Organs (liver, kidneys, heart and brain) were quickly
dissected and collected in ice-cold 0·9% NaCl. Soleus
muscles were dissected and immediately frozen and
stored in liquid nitrogen awaiting ouabain binding assays.
Organs were disrupted using a Ultra-Turrax homogenizer
and further homogenized in a glass dounce homogenizer
equipped with a tightly fitting pestle in 5 ml homogen-
ization buﬀer containing 250 mM sucrose, 10 mM
HEPES–Tris at pH 8·0 and 1 mM DTT. Trypan blue
exclusion tests showed that virtually 100% of the cells
were disrupted. Cellular protein content was measured
according to Lowry (1951), using BSA as a reference.
Eﬀect of pentachlorophenol on thyroid hormone glucuronidation
by cardiac fibroblasts
Cardiac fibroblasts, isolated from neonatal rats as described
earlier (van der Heide et al. 2002) and grown in a 24-well
culture dish, were washed with 1 ml saline, and then
incubated in 1·5 ml culture medium to which 100 nM T3
or 100 nM T4 was added (using 10
6 c.p.m./ml [125I]T3
or [125I]T4 respectively as tracer) and 1 µM penta-
chlorophenol (PCP) at 37 C in a 5% CO2 atmosphere.
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Samples (500 µl) of the incubation medium were taken at
regular time intervals and analyzed by Sephadex LH-20
column chromatography (Mol & Visser 1985). We have
previously established that the water-soluble fractions
represent glucuronidated metabolites only (van der Heide
et al. 2002). Fractions were analyzed for 125I activity in a
-counter (Packard Cobra II, Packard Instruments Co.,
Meriden, CT, USA).
UGT assays
UGT enzyme assays were carried out essentially as
described in Beetstra et al. (1991).
Phenol-UGT In short, homogenates (100 µl with a
protein concentration of 1 mg/ml) were incubated with
1 mM pNP in a total volume of 200 µl incubation medium
(in a final concentration of 100 mM Tris–HCl, 5 mM
MgCl2, 0·05% Brij56 at pH 7·4) in the presence or
absence of 5 mM UDPGA (30 min at 37 C). The
reaction was quenched by adding 3·8 ml 0·1 M ice-cold
NaOH and absorbance of the unconjugated pNP was
measured at 405 nm. Specific phenol-UGT activity is
expressed in mol pNP/µg per min.
Androsteron-UGT A 100 µl homogenate suspension,
with a protein concentration of 1 mg/ml, was incubated
with 100 µM androsteron using [3H]androsteron as tracer,
in a total volume of 200 µl incubation medium (100 mM
Tris–HCl, 5 mM MgCl2, 0·05% Brij56 at pH 7·4) in the
presence or absence of 5 mM UDPGA (30 min at 37 C).
The reaction was quenched by adding 2 ml ice-cold
distilled water. To separate the water-soluble phase from
the water-insoluble phase 2 ml ethyl acetate was added
and mixed thoroughly. Samples were centrifuged for
10 min at 150 g and the ethyl acetate phase was removed.
These steps were repeated once with fresh ethyl acetate,
after which the water phase, containing conjugated
androsteron, was analyzed for 3H activity in a -counter
(Packard Cobra II, Packard Instruments Co.). Specific
androsteron-UGT activity is expressed as mol
androsteron/µg per min.
-Glucuronidase
-Glucuronidase activity was assayed according to
Fishman (1974). In short, 100 µl homogenate, with a
protein concentration of 1 mg/ml, was incubated with
1 mM phenolphthalein--glucuronide in a total volume of
250 µl incubation medium (70 mM acetic acid at pH 5·0)
for 60 min at 37 C. Incubations without protein were
used as a negative control; a commercial purified
-glucuronidase preparation was used as a positive control.
Phenolphthalein served as a standard. The reaction was
quenched by adding 250 µl ice-cold 5% trichloroacetic
acid (TCA). Samples were neutralized by adding 500 µl
glycine at pH 12·9. Absorbance was measured at 540 nm.
Specific -glucuronidase-UGT activity was defined as
mol phenolphthalein/µg per min.
Deiodinases
Assays for deiodinase activities were performed essentially
as described by Visser et al. (1988).
Deiodinase type I Homogenates (10 µg) were incubated
for 15 min at 37 C with 1 µM rT3 and tracer ([125I]rT3,
106 c.p.m./ml) in 200 µl incubation medium (100 mM
phosphate buﬀer, 2 mM EDTA, 10 mM DTT at pH 7·2)
in the presence or absence of 100 µM PTU. The reaction
was quenched by adding 100 µl 5% ice-cold BSA followed
by 500 µl 10% TCA for deproteinization. Samples were
centrifuged (15 min at 4 C, 1500 g) and 500 µl of the
supernatant was acidified with 500 µl 1·0 M HCl. Liber-
ated iodide was analyzed by Sephadex LH-20 column
chromatography, collecting the first three 1 ml 0·1 M HCl
eluates. A crude liver homogenate of an untreated animal
served as a positive control. The specific deiodinase type I
activity was thus measured as the PTU-sensitive outer ring
deiodination of rT3.
Deiodinase type II The methods were the same as in our
deiodinase type I assays, except for using 0·5 µM T4 as a
substrate and 20 mM DTT. PTU was omitted from the
incubation medium.
Ouabain binding assay
The Na+/K+-ATPase concentration in soleus muscle was
quantified by measuring [3H]ouabain binding capacity in
the presence of vanadate (VO4) (Nørgaard et al. 1983).
Thawed samples (4–8 mg) were pre-washed twice for
10 min at 37 C in unlabeled buﬀer solution (24 mM Tris,
3 mM MgSO4, 1 mM VO4, 250 mM sucrose, pH 7·3) to
remove any Na+ and K+ present, so as to avoid inter-
ference with the binding of ouabain and/or vanadate.
Samples were incubated (37 C, 120 min) in a buﬀer
containing 2·2 MBq/ml [3H]ouabain and 1 µM unlabeled
ouabain. Unspecific binding was assessed by incubating a
set of muscle samples in the same buﬀer but with 1 mM
unlabeled ouabain. Unbound [3H]ouabain was removed
with four 30-min washing steps with ice-cold unlabeled
buﬀer solution. Each sample was then weighed and put
into a counting vial, to which 0·5 ml 5% TCA containing
0·1 mM ouabain was added. Finally, after a 16-h extrac-
tion period (4 C), 3 ml scintillation cocktail (Optifluor)
was added and the 3H activity was measured by liquid
scintillation counting (Minaxi Tri-carb, 4000 series;
Packard Bioscience BV, Groningen, The Netherlands).
Specific binding capacity was defined as mol [3H]ouabain
per g wet weight.
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Statistics
All data are shown as means... unless indicated
otherwise. Statistical significance was evaluated by
Student’s t-test or Welch’s alternate t-test where appro-
priate. Statistical significance was accepted at P0·05.
The number of observations (n) is shown in parentheses.
Results
Verifying thyroid status
Table 1 shows that the relative weights of heart and
kidneys were significantly increased in hyperthyroid rats,
and that the relative weights of heart and liver were
significantly decreased in hypothyroid rats. During dissec-
tion it was evident that hyperthyroid organs were much
more richly innervated by blood vessels than their controls
and hypothyroid organs less (data not shown). It is well
established from studies in rat and human skeletal muscle
that ouabain binding site density reflects the total popu-
lation of functional Na+/K+ pumps (Clausen 1998), which
changes proportionally to thyroid status (Kjeldsen et al.
1984, 1986, Everts 1996). Table 2 shows that soleus
muscle from hyperthyroid rats expressed significantly more
ouabain binding sites than their controls, whereas
hypothyroid rats expressed fewer binding sites. The results
show that the applied treatments eﬃciently induced
hyper- and hypothyroidism in our experimental animals.
Deiodinase types I and II
In agreement with observations reviewed by Köhrle
(1999), we found that deiodinase type I activity in control
animals was more than tenfold higher in liver and kidney
than deiodinase type II activity (compare Fig. 1a and b).
In control heart and brain, however, the activities of
deiodinase type I were of the same order of magnitude,
i.e. around 6 fmol/µg per min. Cardiac and cephalic
deiodinase type II activities were also of the same order of
magnitude, i.e. around 0·3 fmol/µg per min.
Figure 1a further shows that deiodinase type I activities
in liver and kidneys paralleled thyroid status (i.e. increased
in hyperthyroidism, although not statistically significant for
hyperthyroid kidney, and decreased in hypothyroidism), a
result that is in line with other studies (Köhrle et al. 1991).
In heart and brain, deiodinase type I activities were
unaﬀected by thyroid status. Deiodinase type II activities
were significantly increased in hyperthyroid kidney. In
hypothyroid liver and kidney, deiodinase type II only
displayed a trend towards decreased specific activities
(Fig. 1b).
Eﬀect of PCP
One micromolar PCP inhibits glucuronidation of T4 and
T3 by neonatal cardiac fibroblasts, as measured by the
appearance of water-soluble glucuronated iodothyronine
metabolites by 89 and 75% respectively (Fig. 2).
UGTs
Phenol-UGT Phenol-UGT activities did not respond
to a hyperthyroid status (Fig. 3). Hepatic and renal
Table 1 Relative wet organ weights, expressed as a percentage of body weight for
hyperthyroid rats and their controls, and for hypothyroid rats and their controls
% of body weight P value
(a) Hyperthyroid rats
Liver (n=4) Control 4·320·10 1
Hyperthyroid 4·320·07
Heart (n=4) Control 0·370·01 0·0004
Hyperthyroid 0·560·03
Kidneys (n=4) Control 0·720·02 ,0·0001
Hyperthyroid 1·020·01
(b) Hypothyroid rats
Liver (n=4) Control 4·060·14 0·0017
Hypothyroid 3·010·13
Heart (n=4) Control 0·470·03 0·004
Hypothyroid 0·300·02
Kidneys (n=4) Control 0·570·12 0·69
Hypothyroid 0·500·11
Table 2 [3H]ouabain binding sites of soleus muscle of hyper- and
hypothyroid rats and their respective controls (pmol/g wet weight).
Data represent meansS.E.M. of 6–18 observations from two to six
animals. P values are with respect to controls
[3H]ouabain binding sites
(pmol/g wet weight) P value
Group
Controls (n=6) 2446
Hyperthyroid rats (n=4) 47727 0·00036
Hypothyroid rats (n=2) 353 ,0·0001
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phenol-UGT activities were decreased in hypothyroidism,
being significant only in liver (P,0·05). In heart, a
specific activity of 2–4 pmol/µg per min was found, which
did not change significantly with the thyroid status of the
animal.
Androsteron-UGT In Table 3, hepatic androsteron-
UGT activities are shown. In hyper- as well as hypothy-
roid liver homogenates, specific activities were decreased,
being significant only in hypothyroid liver (P,0·05). In
kidneys and brain, activities were around 100-fold lower
and it was therefore not possible to obtain reliable esti-
mates of androsteron-UGT activity in these organs. In the
heart, androsteron-UGT activity was about tenfold lower
than in liver, but well above detection limits and was not
influenced by thyroid status (data not shown).
-Glucuronidase
All organ homogenates contained -glucuronidase
activities. The lowest activity levels were measured in
the heart, which were decreased by 77% in hypothyroid
animals (Fig. 4). No eﬀects of experimental hypo- or
hyperthyroidism on specific -glucuronidase activities
were observed in liver, kidneys and brain.
Discussion
In many studies diﬀerent UGT activities have been
measured, but most of these involved toxic xenobiotics
and were performed in liver. This study investigated the
involvement of hepatic as well as non-hepatic UGT and
-glucuronidase activities in the metabolism of endogen-
ous substrates, e.g. thyroid hormones, and their putative
Figure 1 (a) Specific deiodinase type I (D1) activities in whole
organ homogenates of hyper- and hypothyroid rats (n=4;
hypothyroid brain, n=2; hypothyroid kidney, n=8; meansS.E.M.,
*P0·05 and **P0·01 with Welch’s alternate t-test). Please note
the different scales of the primary and secondary y-axes.
(b) Specific deiodinase type II (D2) activities in whole organ
homogenates of hyper- and hypothyroid rats (n=4; hypothyroid
brain and kidney, n=2; meansS.E.M., **P0·01 with Student’s
t-test). ctrl hyper, hyperthyroid control; hyper, hyperthyroid; ctrl
hypo, hypothyroid control; hypo, hypothyroid.
Figure 2 Production of thyroid hormone (TH) glucuronides by
cardiac fibroblasts of neonatal rats exposed to 1 M PCP, at
t=48 h (T4G control, n=6; T3G control, n=7; with PCP, n=8;
meansS.E.M., **P0·01 with Welch’s alternate t-test). T4G,
T4-glucuronide; T3G, T3-glucuronide.
Figure 3 Specific phenol-UGT activities in whole organ
homogenates of hyper- and hypothyroid rats (n=4, ND=not
detectable, meansS.E.M., *P0·05 with Welch’s alternate t-test).
ctrl hyper, hyperthyroid control; hyper, hyperthyroid; ctrl hypo,
hypothyroid control; hypo, hypothyroid.
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role in cycling thyroid hormones in and from a pool of
biologically inactive conjugated iodothyronines. Liver
and kidneys play a stabilizing role in circulating thyroid
hormone levels (Köhrle et al. 1991, Hennemann et al.
2001) and we have put forward the hypothesis that cardiac
fibroblasts play a stabilizing role as such in heart tissue
(van der Heide et al. 2002). Because glucuronidation is
generally accepted to be a clearance mechanism, we
would predict increased and decreased UGT activities
in hyper- and hypothyroid organs respectively. Because
-glucuronidase has the capacity to deconjugate glucuro-
nidated iodothyronines, this enzyme potentially plays a
role in mobilizing re-activated thyroid hormones from a
pool of inactive iodothyronines. Therefore, we predicted
reciprocal eﬀects on -glucuronidase activity with respect
to UGT activities in response to changing thyroid status.
From the present study, it appears that mainly hepatic
phenol-UGT (UGT1A9) activity is sensitive to hypothy-
roidism. This result is partly in line with our hypothesis,
which predicts that with low circulating T3 levels a
reduced activity would be appropriate to increase the
bioavailability of thyroid hormone. Parallel with phenol-
UGT, androsteron-UGT (UGT2B7) activity, mainly in
liver, is also sensitive to hypothyroidism, although the
specific enzyme activity is several orders of magnitude
lower than that of phenol-UGT. Measured at the gene
expression level, primarily UGT1 isozymes were found to
be diﬀerentially influenced by iodothyronine levels: in vivo
T3 treatment aﬀected mRNA levels of UGT1 isozymes in
primary cultures of rat hepatocytes, resulting in an increase
of UGT1A6, and decreases of UGT1A1 and UGT1A5
mRNA levels. Isozymes of the UGT2 family, e.g.
UGT2B1 and UGT2B3, were not sensitive to T3
(Masmoudi et al. 1996, 1997a,b, Li et al. 1999). Our results
obtained on UGT1A1 agree with these observations.
Furthermore, we found that androsteron-UGT, a member
of the UGT2 family, is sensitive to hypothyroidism.
In heart, phenol-UGT as well as androsteron-UGT
activities were present, albeit not responsive to thyroid
status. Both hepatic UGT activities were sensitive to
hypothyroidism, as the activity of this enzyme activity was
decreased in hypothyroidism. Apparently, the responsive-
ness of these UGT1 isozymes is organ specific. The
glucuronidating capacity of the liver is probably an expres-
sion of its role in the biliary excretion of conjugated
exogenous and endogenous substrates.
The specific phenol-UGT activities we measured in
liver and heart of adult rats were in the same order of
magnitude of those measured in neonatal rat tissues in our
previous study (van der Heide et al. 2002). In whole liver
homogenate, specific activities were higher in adult than
in neonatal tissue, whereas in whole heart homogenate
activities were lower. These results could indicate that
hepatic glucuronidation of iodothyronines is relatively
more important in adult life, whereas cardiac glucuroni-
dation of thyroid hormones is more important in the
neonatal period. This hypothesis should be investigated in
specifically designed experiments.
Interestingly, we found that -glucuronidase activity
is sensitive to hypothyroidism only in heart. There is,
however, no reciprocal correlation with the UGT activi-
ties. Both UGTs as well as -glucuronidase activities
decrease in hypothyroidism. UGTs and -glucuronidase
apparently do not jointly participate in a cycle of
de-activating and re-activating of thyroid hormones.
However, -glucuronidase is a pleiotropic enzyme
(Fishman 1974), and it is possible that a high basal activity
masks subtle changes in enzyme activity related to thyroid
hormone metabolism.
Hays & Hsu (1988) reported that T4 glucuronides have
lower aﬃnities for plasma proteins than unconjugated
T4. In addition, Hays & Cavalieri (1992) found that T4
glucuronide is a substrate for deiodinase type I, resulting
in T3 glucuronide, which is subsequently deconjugated
to form T3. Through this metabolic pathway, the
glucuronidation of T4 might represent a mechanism of
fine-tuning the thyroid hormone level by keeping a pool
of prohomone available for deiodination.
PCP is a known inhibitor of a number of diﬀerent
enzymes (Igisu et al. 1993, Moorthy & Randerath 1996,
Table 3 Androsteron-UGT activity in liver homogenates of
hyper- and hypothyroid rats and their respective controls
(pmol/g per min, P value with respect to controls, n=4)
Specific activity
(pmol/g per min) P value
Group
Controls 0·660·13
Hyperthyroid rats 0·330·04 0·094
Control 0·890·12
Hypothyroid rats 0·350·16 0·036
Figure 4 Specific -glucuronidase activities in whole organ
homogenates of hyper- and hypothyroid rats (n=4; hypothyroid
brain, n=2; meansS.E.M., *P0·05 with Student’s t-test). ctrl
hyper, hyperthyroid control; hyper, hyperthyroid; ctrl hypo,
hypothyroid control; hypo, hypothyroid.
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Kester et al. 2000), and it has also been used for selective
inhibition of sulfation (Mulder 1986). However, from the
inhibitory action of PCP on the glucuronidating capacity
of fibroblasts and, hence, UGT activity, we conclude that
PCP cannot be used to discriminate between water-
soluble sulfated or glucuronidated thyroid hormone
metabolites. This is supported by results obtained by
others, who report that PCP inhibits sulfation as well as
glucuronidation of 1-naphthol and iodothyronines (Schuur
et al. 1999, Bostrom et al. 2000).
UGTs are not only involved in conjugating and clearing
exogenous substrates, but also in thyroid hormone metab-
olism. These diﬀerent roles of UGTs in the mammalian
body are exemplified by the observation that xenobiotics
and T3 diﬀerentially regulate bilirubin UGT in rat liver
microsomes (Goudonnet et al. 1990). The eﬀects of
diﬀerent exogenous substrates were found to be additive
(Jemnitz et al. 2000), indicating diﬀerent pathways for the
induction of UGTs. This is in line with the observation of
Masmoudi and co-workers (1997a) who found that the
transcriptional control of the UGT1A1 gene required
de novo protein synthesis, whereas the activation induced
by 3-methylcholanthrene did not. Results from these
studies suggest that diﬀerent UGT induction pathways
are coupled to distinctive roles of UGT isozymes, e.g.
xenobiotics clearance and thyroid hormone metabolism.
In summary, cardiac -glucuronidase, albeit in low
levels, and hepatic UGT activities were responsive only
to experimental hypothyroidism. Although a high basal
activity of the pleiotropic -glucuronidase masking subtle
activity changes in response to thyroid status cannot be
ruled out, we conclude that hepatic, renal and cardiac
UGT and -glucuronidase activities are not regulated
reciprocally with thyroid status.
We are currently investigating possible physiological
eﬀects of glucuronidated iodothyronines on cardiomyocyte
cell function, employing the rat cardiac myoblast cell line
H9c2(2–1) and monitoring cell proliferation and diﬀeren-
tiation, and the expression of appropriate protein markers
(e.g. MHC isoforms and SERCA).
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